The global ADHD Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on ADHD Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall ADHD Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of ADHD Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their ADHD Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Eli Lilly
Janssen Pharmaceuticals, Inc.
Shire
Perdue Pharma
Glaxosmith Kline
Novartis
Celltech Group
Johnson & Johnson

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Stimulants (Amphetamines, Methylphenidate)
Non-Stimulants
Antidepressants
Blood Pressure Medicines

Segment by Application
Adults
Children